Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Pulmonary changes caused by cytostatic drugs].

G Akoun, B Milleron, C Mayaud

    Annales De Medecine Interne
    |January 1, 1985
    PubMed
    Summary

    Cytostatic drugs can cause iatrogenic lung disease, posing diagnostic challenges. Early identification of drug-induced lung conditions is crucial for patient outcomes.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [Recommendations of French specialists on screening for lung cancer].

    Revue des maladies respiratoires·2021
    Same author

    Potential lung cancer screening outcomes using different age and smoking thresholds in the ANRS-CO4 French Hospital Database on HIV cohort.

    HIV medicine·2019
    Same author

    [IoNESCO trial: Immune neoajuvant therapy in early stage non-small cell lung cancer].

    Revue des maladies respiratoires·2018
    Same author

    [Structuring the French thoracic oncology over the last 20 years].

    Revue des maladies respiratoires·2017
    Same author

    [Current knowledge on perioperative treatments of non-small cell lung carcinomas].

    Revue des maladies respiratoires·2017
    Same author

    Pazopanib or placebo in completely resected stage I NSCLC patients: results of the phase II IFCT-0703 trial.

    Annals of oncology : official journal of the European Society for Medical Oncology·2017

    Area of Science:

    • Pulmonology
    • Oncology
    • Pharmacology

    Context:

    • Over 80 drugs can induce lung disease, with cytostatic agents being a primary cause of iatrogenic lung conditions.
    • Specific cytostatic drug classes implicated include intercalating agents, alkylating agents (e.g., busulfan), and antimetabolites (e.g., methotrexate).

    Purpose:

    • To highlight the diagnostic complexities of cytostatic drug-induced lung disease.
    • To emphasize the importance of early diagnosis in managing these adverse drug reactions.

    Summary:

    • Cytostatic drug-induced lung disease diagnosis relies on integrated clinical, radiological, functional, histopathological, and biological data.
    • Bronchoalveolar lavage is key for hypersensitivity reactions, while toxic mechanisms, like drug-induced pulmonary fibrosis, present greater diagnostic challenges.
    • Early detection is critical for effective management and improved patient prognosis.

    Impact:

    • Improved diagnostic strategies for cytostatic drug-induced lung disease.
    • Enhanced clinical awareness and timely intervention for patients receiving cytostatic therapies.
    • Reduced morbidity and mortality associated with iatrogenic lung injury from chemotherapy.

    Related Experiment Videos